Key result
Papillary muscle LGE is linked to ~7-fold higher ventricular arrhythmia risk in mitral regurgitation.
Why the study?
Papillary muscle late gadolinium enhancement (LGE) may occur in non-MVP mitral regurgitation, but its association with ventricular arrhythmia across mitral regurgitation etiologies is unclear.
Is late gadolinium enhancement of the papillary muscles on CMR associated with ventricular arrhythmia in patients with mitral regurgitation?
Population
88 patients with mitral regurgitation who underwent CMR
Comparison
MVP (n = 43) vs non-MVP (n = 45)
Design
Observational comparative study
Authors
Loading...
Papillary muscle LGE may flag higher arrhythmia risk in mitral regurgitation; hypothesis-generating and should not yet change practice.
Observational (n=88)
No
Is late gadolinium enhancement of the papillary muscles on CMR associated with ventricular arrhythmia in patients with mitral regurgitation?
Effect estimate: OR 6.84 (95% CI 1.29-36.19)
p-value: p=0.024
In patients with mitral regurgitation, late gadolinium enhancement of the papillary muscles on CMR is significantly associated with ventricular arrhythmia.
Lim et al. (2021) conducted an observational in Mitral regurgitation (n=88). Late gadolinium enhancement of papillary muscles vs. No late gadolinium enhancement was evaluated on Ventricular arrhythmia (OR 6.84, 95% CI 1.29-36.19, p=0.024). Late gadolinium enhancement of the papillary muscles was significantly associated with ventricular arrhythmia (OR 6.84) in patients with mitral regurgitation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: